Doctors, patients and the racial mortality gap

Journal of Health Economics

Volumn 32, Issue 5, 2013, Pages 895-908

  Simeonova, Emilia ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Adherence to medical therapy; Health inequality; Health production; Racial mortality gap

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

DATA SET; HEALTH CARE; HEALTH POLICY; HEALTH SERVICES; MORTALITY; PANEL DATA; RACIAL DISPARITY;

AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; CHRONIC PATIENT; DOCTOR PATIENT RELATION; GENERAL PRACTITIONER; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNDERSERVED; MEDICATION COMPLIANCE; MORTALITY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; RACE DIFFERENCE; SOCIAL STATUS; TREATMENT RESPONSE;

ADHERENCE TO MEDICAL THERAPY; HEALTH INEQUALITY; HEALTH PRODUCTION; I10; I12; I14; RACIAL MORTALITY GAP;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MORTALITY; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84882988500     PISSN: 01676296     EISSN: 18791646     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2013.07.002     Document Type: Article

References (38)

1. Alexander M., Grumbach K., Remy L., Rowell R., Massie B.M. Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. American Heart Journal 1999, 137(May (5)):919-927.
2. American Heart Association Heart disease and stroke statistics-2013 update. Circulation 2013, 127:e5-e245.
3. Arday S.L., Arday D.R., Monroe S., Zhang J. HCFA's racial and ethnic data: current accuracy and recent improvements. Health Care Financ Rev 2000, 21:107-116.
4. Bach P., et al. Primary care physicians who treat blacks and whites. The New England Journal of Medicine 2004, 351:575-584.
5. Balsa A., McGuire T. Prejudice, clinical uncertainty and stereotypes as sources of health disparities. Journal of Health Economics 2003, 22(1):89-116.
6. Barnato A.E., et al. Hospital-level racial disparities in acute myocardial infarction treatment and outcomes. Medical Care 2005, 43(April (4)).
7. Bogart L.M., Catz S.L., Kelly J.A., Benotsch E.G. Factors influencing physicians' judgements of adherence and treatment decisions for patients with HIV disaease. Medical Decision Making 2001, 21(February (1)).
8. Bradley E.H., et al. Racial and Ethnic differences in times to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA 2004, 292(13):1563-1572.
9. Bristow M. β-Adrenergic receptor blockade in chronic heart failure. Circulation 2000, 101:558-569.
10. Charles K., Erik H., Nikolai R. Conspicuous consumption and race. The Quarterly Journal of Economics 2009, 124(2):425-467.
11. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987, 40(5):373-383.
12. Cohn J.N., Fowler M.B., Bristow M.R., Colucci W.S., Gilbert E.M., Kinhal V., Krueger S.K., Lejemtel T., Narahara K.A., Packer M., Young S.T., Holcslaw T.L., Lukas M.A. Safety and efficacy of carvedilol in severe heart failure. Journal of Cardiac Failure 1997, 3(3).
13. Croft J.B., et al. Heart failure survival among older adults in the united states a poor prognosis for an emerging epidemic in the Medicare population. Archives of Internal Medicine 1999, 159:505-510.
14. Cutler D.M, Wendy E. Thinking outside the pillbox - medication adherence as a priority for health care reform. NEJM 2010, 362(April):17.
15. Cutler D., Lleras-Muney A. Education and Health 2011, unpublished manuscript.
16. Grossman M. Education and nonmarket outcomes. Handbook of the Economics of Education 2006, North-Holland, Elsevier Science, Amsterdam. E. Hanushek, F. Welch (Eds.).
17. Dries D.L., Exner D.V., Gersh B.J., Cooper H.A., Carson P.E., Domanski M.J. Racial differences in the outcome of left ventricular dysfunction. The New England Journal of Medicine 1999, 340:609-616.
18. Exner D., Daniel D., Michael D., Jay C. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compare with white patients with left ventricular dysfunction. The New England Journal of Medicine 2001, 344:1351-1357.
19. Ferguson J. Highlights of the 72nd Scientific Sessions of the American Heart Association. Circulation 2000, 102:E1-E5.
20. Gellad W., Jerry G., Elizabeth M. "A Review of Barriers to Medication Adherence" RAND Technical Report 765 available at the RAND publications website 2009.
21. Goldman D., Smith J.P. Can patient self management help explain the SES health gradient?. Proceedings of the National Academy of Sciences 2002, 99(August (16)).
22. Institute of Medicine, "Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care" Washington: National Academies Press, 2002.
23. Joshi A.V., D'Souza A.O., Madhavan S.S. Differences in hospital length-of-stay, charges, and mortality in congestive heart failure patients. Congestive heart failure (Greenwich, CT) 2004, 10(2):76-84.
24. LaVeist T., Kim N., Janice B. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Medical Care Research and Review 2000, 57(Suppl. 1):146-161.
25. Levy D., et al. Long-Term Trends in the Incidence of and Survival with Heart Failure. NEJM 2002, 347(October):1397-1402. number 18.
26. McCullough P.A., Philbin E.F., Spertus J.A., Kaatz S., Sandberg K.R., Weaver W.D. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. Journal of American College of Cardiology 2002, 39:60-69.
27. Mukamel L., Murthy A., Weimer D Racial differences in access to high-quality cardiac surgeons. American Journal of Public Health 2000, 90(November (11)).
28. Murphy N.F., et al. National survey of the prevalence, incidence, primary care burden and treatment of heart failure in Scotland. Heart 2004, 90:1129-1136.
29. Oster A., Bindman A.B. Emergency department visits for ambulatory care sensitive conditions: insights into preventable hospitalizations. Medical Care 2003, 41(2):198-207.
30. Ostenberg L., Blaschke T. Adherence to Medication. New England Journal of Medicine 2005, 353:387-397.
31. Ostrop N.J., Hallett K.A., Gill M.J. Long-term patent adherence to antiretroviral therapy. Pharmacotherapy 2000, 36(6).
32. Rivkin S.G., Eric H., John K. Teachers, schools, and academic achievement. Econometrica 2005, 73(March (2)):417-458.
33. Rossack J. Education on medication adherence will reduce costs, improve outcome. Psychiatric News May 7 2004.
34. Rothenberg B., et al. Explaining disparities in access to high-quality cardiac surgeons. Annals of Thoracic Surgery 2004, 78(July (1)).
35. Senni M., Tribouilloy C.M., Rodeheffer R.J., Jacobsen S.J., Evans J.M., Bailey K.R., Redfield M.M. Congestive heart failure in the community. Circulation 1998, 98:2282-2289.
36. Silke B. Beta-blockade in CHF: pathophysiological considerations. European Heart Journal Supplements 2006, 8(Suppl. C):C13-C18.
37. Skinner J., et al. Mortality after Acute Myocardial Infarction in Hospitals That Disproportionately Treat Black Patients. Circulation 2005, October.
38. Waagstein F., Hjalmarson A., Swedberg A., Bristow M.R., Gilbert E.M., Camerini F., Fowler M.B., Silver M.A., Johnson M.R., Goss F.G. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. The Lancet 1993, 342(8885).